Publications by authors named "Laura Cesini"

Claim this Profile
C
Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study.
Mario Tumbarello, Gabriele Giuliano, Marianna Criscuolo, Maria Ilaria Del Principe, Cristina Papayannidis, Laura Cesini

J Antimicrob Chemother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group.
Fabio Forghieri, Francesca Bettelli, Simona Sgromo, Gianpaolo Nadali, Maria Ilaria Del Principe, Laura Cesini

Ann Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Myeloid Leukemia with NPM1 Mutation and Disseminated Leukemia Cutis: Achievement of Molecular Complete Remission by Venetoclax/Azacitidine Combination in a Very Old Patient.
Pasquale Niscola, Carla Mazzone, Stefano Fratoni, Nicolina Rita Ardu, Laura Cesini

Acta Haematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute hepatitis-like presentation with cholestasis of CBFB-MYH11-positive acute myeloid leukemia in an adult male: a case report.
Irene Spinelli, Adriano De Santis, Laura Cesini, Mara Riminucci, Alessandro Corsi

J Med Case Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML.
Matteo Molica, Salvatore Perrone, Carla Mazzone, Laura Cesini, Martina Canichella

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced transmission of carbapenemase-producing (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic.
Alessandra Micozzi, Giovanni Manfredi Assanto, Laura Cesini, Clara Minotti, Claudio Cartoni

JAC Antimicrob Resist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging tyrosine kinase inhibitors for the treatment of adult acute lymphoblastic leukemia.
Michela Ansuinelli, Laura Cesini, Sabina Chiaretti, Robin Foà

Expert Opin Emerg Drugs· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin.
Matteo Molica, Salvatore Perrone, Carla Mazzone, Pasquale Niscola, Laura Cesini

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.
Laura Cesini, Camilla Frieri, Claudia Baratè, Federica Sorà, Massimiliano Bonifacio

Eur J Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of Clinically Significant (≤10 g/dL) Late Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib.
Laura Cesini, Ida Carmosino, Massimo Breccia, Daniela De Benedittis, Sara Mohamed

Oncol Res Treat· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment.
Roberto Latagliata, Pasquale Niscola, Luana Fianchi, Maria Antonietta Aloe Spiriti, Luca Maurillo, Laura Cesini

Hematol Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib-based therapy impaired neutrophils microbicidal activity in patients with chronic lymphocytic leukemia during the early phases of treatment.
Alessandro Prezzo, Filomena Monica Cavaliere, Caterina Bilotta, Tancredi Massimo Pentimalli, Metello Iacobini, Laura Cesini

Leuk Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia.
Andrea Visentin, Marina Deodato, Francesca R Mauro, Francesco Autore, Gianluigi Reda, Laura Cesini

Hematol Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study).
Pellegrino Musto, Vittorio Simeon, Nicola Cascavilla, Antonietta Falcone, Maria Teresa Petrucci, Laura Cesini

Ann Hematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical results according to age in patients with chronic myeloid leukemia receiving imatinib frontline: The younger, the later, the worse?
Roberto Latagliata, Massimo Breccia, Ida Carmosino, Laura Cesini, Daniela De Benedittis

Eur J Haematol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment.
Laura Cesini, Agostina Siniscalchi, Sara Grammatico, Alessandro Andriani, Alessia Fiorini

Eur J Haematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing treatment-related peripheral neuropathy in patients with multiple myeloma.
Sara Grammatico, Laura Cesini, Maria Teresa Petrucci

Blood Lymphat Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis